Angiography Devices Market

The global market value of the angiography devices market was valued at USD 13.09 billion in 2023 and is projected to grow at a CAGR of 5.1% during the forecast period. Investments in the healthcare sector, the increasing geriatric population, and the rising prevalence of cardiovascular diseases (CVDs) are other prominent factors responsible for market growth. Rising healthcare expenditure in low-income and middle-income countries to prevent the deaths caused by cardiovascular diseases.

The rising prevalence of cardiovascular diseases is due to increasing obesity and diabetes patients all over the world. Technological advancements in healthcare are transforming medical treatments, driving efficiency, and improving patient outcomes. Technological advancements in healthcare are transforming medical treatments, driving efficiency, and improving patient outcomes.

Growth Drivers

Technological advancements in imaging systems and growing demand for minimally invasive procedures with an increasing number of cardiovascular patients all around the world. The rising number of chronic heart disease cases and innovations in angiography devices, such as improved imaging quality (e.g., 3D imaging, high-resolution detectors), reduced radiation exposure, and integration of artificial intelligence (AI), are significant growth catalysts. These advancements enhance diagnostic accuracy, improve patient outcomes, and support minimally invasive procedures, making the devices more appealing to healthcare providers.

The global rise in the geriatric population, which is more prone to chronic conditions like CVDs, increases the need for diagnostic and interventional procedures. Older adults require frequent monitoring and treatment, driving the utilization of angiography devices. Public health campaigns, government programs, and organizational efforts to raise awareness about cardiovascular health and the importance of early diagnosis contribute to higher demand for angiography devices.

These initiatives encourage timely interventions, further propelling market expansion. Globally, CVDs remain a leading cause of death, necessitating advanced diagnostic and therapeutic tools like angiography devices for early detection and treatment. The growing burden of these conditions, especially in aging populations and developing regions, fuels demand.

Segmentation

Angiography Equipment Product based Segmentation

·         Angiography Systems

·         Catheters

·         Guidewire

·         Balloons

·         Contrast Media

·         Vascular Closure Devices

·         Angiography Accessories

Angiography Equipment Technology based Segmentation

·         X-Ray

·         MRA

·         CT

Angiography Equipment Market Procedure

·         Coronary

·         Endovascular

·         Neurovascular

Angiography Devices market on the basis of Equipment

·         Diagnostic

·         Therapeutic

By Region

·         Asia-Pacific

·         North America

·         Latin America

·         Middle East and Africa

·         Europe

Regional Outlook

On the basis of the regions, the angiography devices market is segmented into 5 regions: Asia-Pacific, North America, Latin America, the Middle East and Africa, and Europe. Due to its well-established healthcare infrastructure, the North America region is the leading segment in the angiography devices market and is expected to dominate the market during the forecast period. Due to the high adoption of advanced medical technologies and substantial healthcare expenditure, the region is witnessing significant growth. Due to the increasing number of geriatric people, the patients with cardiovascular diseases are increasing.

Europe also holds a substantial share of the market. Countries like Germany, France, and the United Kingdom are leading the market, with the focus on early diagnosis and preventive healthcare driving the demand for advanced diagnostic imaging technologies. Due to the rising healthcare expenditure, increasing urbanization in emerging economies, and increasing incidence of lifestyle-related diseases, the Asia-Pacific region is expected to witness significant growth during the forecast period. Japan leads in adopting cutting-edge imaging technologies, while China and India are catching up with increased demand for cost-effective yet advanced devices.

The MEA region holds a smaller share of the global angiography devices market but is poised for steady growth. The market is driven by an aging population, rising chronic disease prevalence, and gradual improvements in healthcare access, particularly in Gulf Cooperation Council (GCC) countries like Saudi Arabia and the UAE. Wealthier nations like Saudi Arabia and the UAE are modernizing healthcare infrastructure under initiatives like Saudi Vision 2030, increasing the adoption of advanced medical devices.

Latin America is an emerging market for angiography devices, with Brazil and Mexico as key players. The region benefits from growing healthcare infrastructure and a rising need for cardiovascular care, though economic challenges temper its pace. Investments in public and private healthcare facilities, particularly in urban areas, support the integration of angiography devices. Brazil’s focus on improving medical access amplifies this trend.

Key Players

·         Boston Scientific

·         Medtronic Plc.

·         Abbott

·         Microport Scientific Corporation

·         B. BRAUN SE

·         KONINKLIJKE PHILIPS N.V.

·         Angiodynamics Inc.

·         GE Healthcare

·         Cardinal Health

·         Siemens Healthineers AG

·         SHIMADZU CORPORATION

·         Other Players